alexa Hypoxia And Inflammation Activate A Sequential Pathway Leading To Tumor Progression | 17416
ISSN: 2157-7013

Journal of Cell Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th World Congress on Cell Science & Stem Cell Research

Matteoantonio Russo and Marco Tafani
ScientificTracks Abstracts: J Cell Sci Ther
DOI: 10.4172/2157-7013.S1.028
Abstract
H IF1 α and NFkB are two transcription factors involved in tumor growth and progression. HIF1 α and NFkB regulate transcription of over a thousand genes that, in turn, control adaptation to hypoxia, metabolic reprogramming, inflammatory-reparative response, extracellular matrix digestion, etc. Interestingly, hypoxia and inflammation have been sequentially bridged in tumors by the discovery that alarmin receptors genes such as RAGE, P2X7 and some TLRs, are controlled by HIF1 α ; and that, in turn, alarmin receptors are activated by alarmins (DAMPs) released by necrotic tumor cells. The signaling of alarmin receptors converges to activate NFkB and proinflammatory gene expression, in surviving tumor cells, evidencing all the hallmarks of the malignant phenotype. Although many pieces of the puzzle have been rightly placed into this hypothetical framework, a number of questions are still waiting to be answered. What is the precise role of the individual HIF-dependent genes? What is the role of the NFkB-dependent gene families in generating the malignant phenotype? What tumor cells (stem cells?) are best responding to the hypoxia adaptation and to the proinflammatory gene expression? How metastasis are generated and conditioned to the final site? How is determined the metastatic pattern in the individual patient? Can inhibitors of HIF and/or NFkB pathway change substantially tumor progression? Recently, drugs have been identified that inhibit one or both transcription factors. Many of these molecules are natural compounds or off-label drugs already used to cure other pathologies and some of them are undergoing clinical trials either alone or in combination with standard anti- tumoral with the primary end-points of a better quality of life and a net increase in survival.
Biography
Matteo A Russo is full Professor of General Pathophysiology at School of Medicine, University of Rome Sapienza, Rome, Italy. He graduated in Medicine and Surgery (1969). Specialized in Cardiology, Oncology and General Pathology, is a Fulbright Scholar (1974-1976) in Philadelphia, at University of Pennsylvania and Temple University, Adjunct Professor of Pathology and Pharmacology (1980-1990) at Temple University and Member of the Research Committee of Italian Ministry of Health (2000-2007). At present, he is Director of the Research Doctorate in Human Pathology of University of Rome, Sapienza; Member of Scientific Committee of Fondazione San Raffele, Milan; Member of Scientific Committee of IRCCS San Raffaele Pisana, Rome. He has published more than 150 papers in reputed journals and serving as an editorial board member of 7 journals.Some research interest: a) Mechanisms of cell volume control independent from ATP-ase Na/K-dependent, b) Ca ++ and cytoskeleton in the pathogenesis of necrosis and apoptosis and c) Proinflammatory genes expression in different human diseases (brain and tumors).
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7